Ligand Pharmaceuticals (LGND): Quarterly Revenue Growth

Official company branding of Ligand Pharmaceuticals Incorporated (LGND)

Ligand Pharmaceuticals (LGND) generates revenue based on licensing fees and Captisol technology, which eliminates the risks of clinical failures. This quarterly revenue growth chart demonstrates the dynamics of these inflows, where -31.60 captures the magnitude of this parameter. The "biotech rentier" strategy minimizes costs, transforming the company into a high-margin intellectual incubator for global pharma blockbusters.

LGND (Ligand Pharma) Quarterly Revenue Growth history from 07/04/2022 to 11/21/2026

Financial and market metric breakdowns for Ligand Pharma (LGND)

- stock price and consensus target price:
General company analysis:LGND - Ligand Pharma
Manufactured products of Ligand Pharmaceuticals Incorporated

Investors evaluate Ligand Pharmaceuticals (LGND) through cash flow dynamics, where the key driver is the QoQ revenue growth rate, measuring the pace of income expansion relative to the same period last year. For the royalty model, this indicator confirms the effectiveness of the patent portfolio regardless of production costs, allowing the chart to timely identify phases of profit acceleration and free cash flow stability.

Key competitors

HLN - Revenue Growth QoQ|Quarterly Revenue Growth Rate kenvue.com|Verona Pharma (VRNA) - Revenue Growth QoQ|Quarterly Revenue Growth Rate Jyong Biotech Limited (MENS)|AMRX (amneal.com) - Quarterly Revenue Growth|PRGO: Quarterly Revenue Increase|Quarterly Sales Growth ALVO (Alvotech Corp)|Quarterly Sales Growth Rate Liquidia Corporation|Quarterly Revenue Growth GLPG (glpg.com)|Quarterly Revenue Increase ANIP|MNKD - Revenue Growth QoQ|Amphastar - Sales Change QoQ|PCRX: Quarterly Revenue Growth|ars-pharma.com - Quarterly Revenue Increase|TBPH (Theravance Biopharma Inc) - Quarterly Revenue Growth|Quarterly Revenue Growth Rate Aquestive Pharma AQST|Quarterly Revenue Growth SCPH|Sales Change QoQ TECX|Revenue Growth QoQ tonixpharma.com TNXP|SXTC (SXT China) - Revenue Dynamics QoQ|Eupraxia Pharmaceuticals - Quarterly Revenue Growth|Quarterly Sales Growth Rate BioHarvest Sciences Inc. BHST|EXOZ: Quarterly Revenue Growth|Oramed (ORMP) - Quarterly Revenue Growth|ENTX (Entera Bio) - Quarterly Revenue Growth|ipatherapeutics.com (HYFT) - Quarterly Sales Growth Rate|Quarterly Revenue Growth ABVC|CPIX (Cumberland Pharmaceuticals Inc) - Quarterly Revenue Increase|Revenue Growth QoQ Quantum BioPharma Corp QNTM|FibroGen Corporation (FGEN) - Quarterly Revenue Growth Rate|TELO: Quarterly Sales Growth|Quarterly Sales Growth Rate Rani Therapeutics Holdings, Inc. RANI|Synergy CHC Corp (SNYR) - Revenue Growth QoQ|RLYB - Quarterly Sales Growth Rate|Revenue Growth QoQ Lexaria Bioscience|Pulmatrix Corp - Revenue Dynamics QoQ|Revenue Growth QoQ ftzy.com.cn (PTHL)|Aptorum Group - Sales Growth QoQ|Quarterly Revenue Growth LYRA (Lyra Therapeutics Inc.)|Quarterly Sales Growth Rate Impact BioMedical (IBO)|TNF Pharmaceuticals - Quarterly Revenue Growth|Quarterly Revenue Growth Rate cbdMD Inc.|PainReform Ltd. (PRFX) - Revenue Growth QoQ|Quarterly Revenue Growth Rate Altamira Therapeutics (CYTO)|Revenue Growth QoQ Lipella Pharmaceuticals, Inc.|OPTN: Quarterly Revenue Increase|Revenue Growth QoQ Pieris (PIRS)|Quarterly Revenue Growth Procaps Group Corp (PROC)|Quarterly Revenue Growth PTPI (petrospharma.com)|Quarterly Revenue Increase QLI|ACELYRIN - Quarterly Revenue Growth|Quarterly Revenue Increase TFFP (TFF Pharmaceuticals Inc.)